Octreotide Acetate

CAS 83150-76-9 17 API suppliersPeptide

Overview

Octreotide Acetate is a synthetic octapeptide that mimics natural somatostatin pharmacologically, inhibiting the secretion of several hormones. It is primarily used in the treatment of acromegaly and severe cases of diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide tumors.

API suppliers (17)

Suppliers of Octreotide Acetate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
Italy2China2Spain1India1Netherlands1United States1Taiwan1Switzerland1

Country recorded for 12 of 17 suppliers.

7 of 17 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

EndocrinologyOncologyGastroenterology
Verified Supplier Partner

Do you supply Octreotide Acetate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.